[{"address1": "1185 Avenue of the Americas", "address2": "3rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.synaptogen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan J. Tuchman M.D., MBA(FAAN)", "age": 76, "title": "CEO & Director", "yearBorn": 1947, "fiscalYear": 2022, "totalPay": 374795, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel L. Alkon M.D.", "age": 81, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1942, "fiscalYear": 2022, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Weinstein", "age": 63, "title": "CFO, Executive VP, Treasurer & Secretary", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 520883, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.195, "open": 0.193, "dayLow": 0.1812, "dayHigh": 0.199, "regularMarketPreviousClose": 0.195, "regularMarketOpen": 0.193, "regularMarketDayLow": 0.1812, "regularMarketDayHigh": 0.199, "beta": 1.56, "forwardPE": -0.12134147, "volume": 74282, "regularMarketVolume": 74282, "averageVolume": 409695, "averageVolume10days": 470380, "averageDailyVolume10Day": 470380, "bid": 0.1942, "ask": 0.199, "bidSize": 2200, "askSize": 800, "marketCap": 4057769, "fiftyTwoWeekLow": 0.18, "fiftyTwoWeekHigh": 1.88, "fiftyDayAverage": 0.25834, "twoHundredDayAverage": 0.55839, "currency": "USD", "enterpriseValue": -27751336, "floatShares": 20162456, "sharesOutstanding": 20390800, "sharesShort": 368250, "sharesShortPriorMonth": 283235, "sharesShortPreviousMonthDate": 1701302400, "dateShortInterest": 1703808000, "sharesPercentSharesOut": 0.018099999, "heldPercentInsiders": 0.01994, "heldPercentInstitutions": 0.015039999, "shortRatio": 1.13, "shortPercentOfFloat": 0.0183, "impliedSharesOutstanding": 20390800, "bookValue": 1.527, "priceToBook": 0.13032089, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -8183357, "trailingEps": -0.85, "forwardEps": -1.64, "lastSplitFactor": "1:4", "lastSplitDate": 1621382400, "enterpriseToEbitda": 2.3, "52WeekChange": -0.8142857, "SandP52WeekChange": 0.21123838, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SNPX", "underlyingSymbol": "SNPX", "shortName": "Synaptogenix, Inc.", "longName": "Synaptogenix, Inc.", "firstTradeDateEpochUtc": 1607437800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d14ff140-0ac6-3af9-a386-f918dc6aa47f", "messageBoardId": "finmb_268943522", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.199, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 31727548, "totalCashPerShare": 1.556, "ebitda": -12063650, "quickRatio": 17.454, "currentRatio": 17.792, "returnOnAssets": -0.25268, "returnOnEquity": -0.02098, "freeCashflow": -3304282, "operatingCashflow": -6890727, "financialCurrency": "USD", "trailingPegRatio": null}]